Incorrect username and/or password, please try again or click to reset.

Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products, EL(21)A/34

2021-11-30 11:00:04 (2 year(s) ago)

Summary

Specific batches of products supplied by Marketing Authorisation Holders and parallel distributor companies are being recalled due to presence of a mutagenic impurity.

Read full MHRA article

Respond to this alert